HIV AIDS

>

Latest News

USPSTF Publishes Final Recommendation Statement on HIV PrEP  image credit prep pill ©magann/stock.adobe.com
USPSTF Publishes Final Recommendation Statement on HIV PrEP

August 23rd 2023

The USPSTF particularly emphasizes effective communication with patients, including adherence support and calls for reducing barriers to PrEP for racial, ethnic, and other minority groups.

2022 Clinical Guideline Toplines: Essential Summaries for Primary Care
2022 Clinical Guideline Toplines: Essential Summaries for Primary Care

December 30th 2022

FDA Approves Novel Capsid Inhibitor for Super-Refractory HIV-1 Infection
FDA Approves Novel Capsid Inhibitor for Super-Refractory HIV-1 Infection

December 23rd 2022

Substantial Drop in HIV Testing among Key Groups during First Year of COVID-19, New CDC Data Reveals
Substantial Drop in HIV Testing among Key Groups during First Year of COVID-19, New CDC Data Reveals

June 28th 2022

FDA Label Expansion Further Simplifies HIV Treatment with Cabotegravir/Rilpivirine
FDA Label Expansion Further Simplifies HIV Treatment with Cabotegravir/Rilpivirine

March 25th 2022

Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.